ZNF385A anticorps (N-Term)

N° du produit ABIN1109584

Détail du produit anti-ZNF385A anticorps

Antigène: ZNF385A (Zinc Finger Protein 385A (ZNF385A))

Épitope: N-Term

Reactivité: Humain, Souris, Rat, Boeuf (Vache)

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ZNF385A est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Séquence: EPAPTLGLFS NYSTMDPVQK AVLSHTFGGP LLKTKRPVIS CNICQIRFNS

Réactivité croisée (Details): Species reactivity (expected):Mouse, Rat, BovineSpecies reactivity (tested):Human

Purification: Purified using peptide immunoaffinity column

Immunogène: The immunogen for anti-ZNF385 antibody: synthetic peptide directed towards the N terminal of human ZNF385

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Reconstitution: Add 50 μL of distilled water to a final concentration of 1 mg/mL.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store lyophilized at 2-8 °C or at -20 °C long term. After reconstitution store the antibody undiluted at 2-8 °C for up to one month or in aliquots at -20 °C long term.

Détails sur ZNF385A

Antigène: ZNF385A (Zinc Finger Protein 385A (ZNF385A))

Autre désignation: ZNF385A (ZNF385A Produits)

Synonymes: anticorps HZF, anticorps RZF, anticorps ZFP385, anticorps ZNF385, anticorps Hzf, anticorps Zfp385, anticorps Znf385a, anticorps si:dkey-228g21.6, anticorps wu:fj44b04, anticorps zinc finger protein 385A, anticorps ZNF385A, anticorps Zfp385a, anticorps znf385a

Sujet: ZNF385 is a 322 amino acid 38 kDa protein containing 3 matrin-type zinc fingers. It is expressed predominantly in the retina and may be involved in transcriptional regulation.Synonyms: HZF, Hematopoietic zinc finger protein, RZF, Retinal zinc finger protein, ZNF385, Zinc finger protein 385A

ID gène: 25946

NCBI Accession: NP_056296

Pathways: Positive Regulation of Response to DNA Damage Stimulus, Negative Regulation of intrinsic apoptotic Signaling, Positive Regulation of fat Cell Differentiation